(-)-epigallocatechin 3-gallate decreases expression ISO RGD:1319867 6480464 epigallocatechin gallate results in decreased expression of EFNB2 mRNA CTD PMID:16084531 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1319867 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of EFNB2 mRNA CTD PMID:22079256 1,2-dimethylhydrazine affects expression EXP 6480464 1, 2-Dimethylhydrazine affects the expression of EFNB2 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:1319867 6480464 Estradiol results in decreased expression of EFNB2 mRNA CTD PMID:16474171 17beta-estradiol multiple interactions ISO RGD:1309497 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EFNB2 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO RGD:1319867 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of EFNB2 mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of EFNB2 mRNA CTD PMID:17404688 , PMID:30165855 17beta-estradiol 3-benzoate multiple interactions ISO RGD:1309497 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EFNB2 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of EFNB2 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1309497 6480464 Tetrachlorodibenzodioxin results in decreased expression of EFNB2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1309497 6480464 Tetrachlorodibenzodioxin affects the expression of EFNB2 mRNA CTD PMID:34747641 2-methylcholine affects expression ISO RGD:1319867 6480464 beta-methylcholine affects the expression of EFNB2 mRNA CTD PMID:21179406 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of EFNB2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of EFNB2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of EFNB2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine decreases expression EXP 6480464 Decitabine results in decreased expression of EFNB2 mRNA CTD PMID:27915011 5-fluorouracil affects response to substance ISO RGD:1319867 6480464 EFNB2 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 , PMID:16217747 5-fluorouracil decreases expression ISO RGD:1319867 6480464 Fluorouracil results in decreased expression of EFNB2 protein CTD PMID:15352031 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:32553695 acrylamide decreases expression ISO RGD:1309497 6480464 Acrylamide results in decreased expression of EFNB2 mRNA CTD PMID:28959563 actinomycin D multiple interactions ISO RGD:1319867 6480464 Dactinomycin inhibits the reaction [Tretinoin results in increased expression of EFNB2 mRNA] CTD PMID:16688769 afimoxifene increases expression ISO RGD:1319867 6480464 afimoxifene results in increased expression of EFNB2 mRNA CTD PMID:16849584 all-trans-retinoic acid multiple interactions ISO RGD:1319867 6480464 Dactinomycin inhibits the reaction [Tretinoin results in increased expression of EFNB2 mRNA] CTD PMID:16688769 all-trans-retinoic acid increases expression ISO RGD:1319867 6480464 Tretinoin results in increased expression of EFNB2 mRNA CTD PMID:16688769 more ... amphetamine decreases expression ISO RGD:1309497 6480464 Amphetamine results in decreased expression of EFNB2 mRNA CTD PMID:30779732 aristolochic acid A increases expression ISO RGD:1319867 6480464 aristolochic acid I results in increased expression of EFNB2 mRNA CTD PMID:33212167 Aroclor 1254 increases expression ISO RGD:1309497 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of EFNB2 mRNA CTD PMID:34858468 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of EFNB2 mRNA CTD PMID:19654921 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of EFNB2 mRNA CTD PMID:19654921 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of EFNB2 mRNA CTD PMID:33053406 atrazine decreases expression ISO RGD:1319867 6480464 Atrazine results in decreased expression of EFNB2 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of EFNB2 mRNA CTD PMID:19770486 , PMID:32417428 benzo[a]pyrene increases methylation ISO RGD:1319867 6480464 Benzo(a)pyrene results in increased methylation of EFNB2 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of EFNB2 mRNA CTD PMID:21569818 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1319867 6480464 7 more ... CTD PMID:20018196 Benzo[k]fluoranthene decreases expression EXP 6480464 benzo(k)fluoranthene results in decreased expression of EFNB2 mRNA CTD PMID:26377693 bisphenol A decreases expression ISO RGD:1319867 6480464 bisphenol A results in decreased expression of EFNB2 mRNA CTD PMID:16474171 , PMID:29275510 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of EFNB2 mRNA CTD PMID:35479511 bisphenol A increases methylation ISO RGD:1309497 6480464 bisphenol A results in increased methylation of EFNB2 gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:1309497 6480464 bisphenol A results in increased expression of EFNB2 mRNA CTD PMID:25181051 more ... bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of EFNB2 mRNA CTD PMID:30951980 butanal increases expression ISO RGD:1319867 6480464 butyraldehyde results in increased expression of EFNB2 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO RGD:1309497 6480464 Cadmium Chloride results in decreased expression of EFNB2 mRNA CTD PMID:33453195 calcitriol multiple interactions ISO RGD:1319867 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of EFNB2 mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:1319867 6480464 Calcitriol results in decreased expression of EFNB2 mRNA CTD PMID:16002434 , PMID:21592394 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 celastrol decreases expression ISO RGD:1319867 6480464 celastrol results in decreased expression of EFNB2 mRNA CTD PMID:17010675 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of EFNB2 mRNA CTD PMID:29980752 chloropicrin increases expression ISO RGD:1319867 6480464 chloropicrin results in increased expression of EFNB2 mRNA CTD PMID:26352163 chlorpyrifos increases expression ISO RGD:1309497 6480464 Chlorpyrifos results in increased expression of EFNB2 mRNA CTD PMID:34858468 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EFNB2 gene CTD PMID:20938992 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of EFNB2 mRNA CTD PMID:28472532 cisplatin multiple interactions ISO RGD:1319867 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of EFNB2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1319867 6480464 Cisplatin results in decreased expression of EFNB2 mRNA CTD PMID:27392435 cocaine increases expression ISO RGD:1309497 6480464 Cocaine results in increased expression of EFNB2 mRNA CTD PMID:15691709 copper atom multiple interactions ISO RGD:1319867 6480464 [NSC 689534 binds to Copper] which results in increased expression of EFNB2 mRNA CTD PMID:20971185 copper atom increases expression ISO RGD:1309497 6480464 Copper results in increased expression of EFNB2 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1319867 6480464 [NSC 689534 binds to Copper] which results in increased expression of EFNB2 mRNA CTD PMID:20971185 copper(0) increases expression ISO RGD:1309497 6480464 Copper results in increased expression of EFNB2 mRNA CTD PMID:30556269 coumestrol multiple interactions ISO RGD:1319867 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol decreases expression ISO RGD:1319867 6480464 Coumestrol results in decreased expression of EFNB2 mRNA CTD PMID:19167446 dibenz[a,h]anthracene decreases expression EXP 6480464 1 more ... CTD PMID:26377693 dorsomorphin multiple interactions ISO RGD:1319867 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EFNB2 mRNA CTD PMID:27188386 Enterolactone multiple interactions ISO RGD:1319867 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNB2 mRNA CTD PMID:19167446 entinostat decreases expression ISO RGD:1319867 6480464 entinostat results in decreased expression of EFNB2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1319867 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EFNB2 mRNA CTD PMID:27188386 flutamide increases expression ISO RGD:1309497 6480464 Flutamide results in increased expression of EFNB2 mRNA CTD PMID:24793618 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EFNB2 gene CTD PMID:20938992 formaldehyde decreases expression ISO RGD:1319867 6480464 Formaldehyde results in decreased expression of EFNB2 mRNA CTD PMID:20655997 furan decreases expression ISO RGD:1309497 6480464 furan results in decreased expression of EFNB2 mRNA CTD PMID:25539665 gedunin decreases expression ISO RGD:1319867 6480464 gedunin results in decreased expression of EFNB2 mRNA CTD PMID:17010675 genistein decreases expression ISO RGD:1319867 6480464 Genistein results in decreased expression of EFNB2 mRNA CTD PMID:16474171 , PMID:26865667 gentamycin decreases expression ISO RGD:1309497 6480464 Gentamicins results in decreased expression of EFNB2 mRNA CTD PMID:33387578 hydrogen peroxide affects expression ISO RGD:1319867 6480464 Hydrogen Peroxide affects the expression of EFNB2 mRNA CTD PMID:20044591 isobutanol multiple interactions ISO RGD:1319867 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of EFNB2 mRNA CTD PMID:29432896 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EFNB2 gene CTD PMID:20938992 Licochalcone B increases expression ISO RGD:1319867 6480464 licochalcone B results in increased expression of EFNB2 mRNA CTD PMID:33647349 lithocholic acid multiple interactions ISO RGD:1319867 6480464 Lithocholic Acid inhibits the reaction [[EPHB4 protein binds to EFNB2 protein] which results in increased phosphorylation of EPHB4 protein] CTD PMID:21479221 menadione decreases expression EXP 6480464 Vitamin K 3 results in decreased expression of EFNB2 mRNA CTD PMID:25270620 methylisothiazolinone increases expression ISO RGD:1319867 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of EFNB2 mRNA CTD PMID:31629900 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1309497 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of EFNB2 mRNA CTD PMID:16809437 N-acetyl-L-cysteine decreases expression ISO RGD:1319867 6480464 Acetylcysteine results in decreased expression of EFNB2 mRNA CTD PMID:16084531 nitrofen increases expression ISO RGD:1309497 6480464 nitrofen results in increased expression of EFNB2 mRNA, nitrofen results in increased expression of EFNB2 protein CTD PMID:30106123 ozone decreases expression EXP 6480464 Ozone results in decreased expression of EFNB2 mRNA CTD PMID:12763052 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of EFNB2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of EFNB2 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1319867 6480464 Acetaminophen results in increased expression of EFNB2 mRNA CTD PMID:21420995 paracetamol decreases expression ISO RGD:1309497 6480464 Acetaminophen results in decreased expression of EFNB2 mRNA CTD PMID:33387578 pentanal increases expression ISO RGD:1319867 6480464 pentanal results in increased expression of EFNB2 mRNA CTD PMID:26079696 phenobarbital affects methylation EXP 6480464 Phenobarbital affects the methylation of EFNB2 gene CTD PMID:19233941 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of EFNB2 mRNA CTD PMID:23811191 potassium chromate increases expression ISO RGD:1319867 6480464 potassium chromate(VI) results in increased expression of EFNB2 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1319867 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of EFNB2 mRNA CTD PMID:22079256 progesterone multiple interactions ISO RGD:1319867 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of EFNB2 mRNA CTD PMID:17404688 progesterone decreases expression ISO RGD:1319867 6480464 Progesterone results in decreased expression of EFNB2 mRNA CTD PMID:17404688 propanal increases expression ISO RGD:1319867 6480464 propionaldehyde results in increased expression of EFNB2 mRNA CTD PMID:26079696 quercetin increases expression ISO RGD:1319867 6480464 Quercetin results in increased expression of EFNB2 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1319867 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of EFNB2 mRNA CTD PMID:19167446 SB 431542 increases expression ISO RGD:1319867 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of EFNB2 protein CTD PMID:25670856 SB 431542 multiple interactions ISO RGD:1319867 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EFNB2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1319867 6480464 Silicon Dioxide analog results in increased expression of EFNB2 mRNA, Silicon Dioxide results in increased expression of EFNB2 mRNA CTD PMID:23806026 more ... sodium arsenite decreases expression ISO RGD:1319867 6480464 sodium arsenite results in decreased expression of EFNB2 mRNA CTD PMID:12727804 more ... streptozocin affects expression EXP 6480464 Streptozocin affects the expression of EFNB2 mRNA CTD PMID:26073000 sulforaphane decreases expression ISO RGD:1319867 6480464 sulforaphane results in decreased expression of EFNB2 mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:1319867 6480464 Sunitinib results in increased expression of EFNB2 mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1319867 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of EFNB2 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1309497 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EFNB2 mRNA CTD PMID:32741896 testosterone decreases expression ISO RGD:1319867 6480464 Testosterone results in decreased expression of EFNB2 mRNA CTD PMID:21592394 testosterone enanthate affects expression ISO RGD:1319867 6480464 testosterone enanthate affects the expression of EFNB2 mRNA CTD PMID:17440010 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of EFNB2 mRNA CTD PMID:17484886 thioacetamide increases expression ISO RGD:1309497 6480464 Thioacetamide results in increased expression of EFNB2 mRNA CTD PMID:34492290 trichostatin A increases expression ISO RGD:1319867 6480464 trichostatin A results in increased expression of EFNB2 mRNA CTD PMID:24935251 trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of EFNB2 mRNA CTD PMID:19042947 triptonide increases expression EXP 6480464 triptonide results in increased expression of EFNB2 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1319867 6480464 tris(2-butoxyethyl) phosphate affects the expression of EFNB2 mRNA CTD PMID:29024780 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of EFNB2 mRNA CTD PMID:17569031 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of EFNB2 mRNA CTD PMID:17127020 tunicamycin decreases expression ISO RGD:1319867 6480464 Tunicamycin results in decreased expression of EFNB2 mRNA CTD PMID:22378314 urethane increases expression ISO RGD:1319867 6480464 Urethane results in increased expression of EFNB2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1319867 6480464 Valproic Acid affects the expression of EFNB2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1319867 6480464 Valproic Acid results in increased expression of EFNB2 mRNA CTD PMID:24383497 more ... vinclozolin affects expression ISO RGD:1309497 6480464 vinclozolin affects the expression of EFNB2 mRNA CTD PMID:19015723 zinc atom multiple interactions ISO RGD:1319867 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of EFNB2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1319867 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of EFNB2 mRNA CTD PMID:18593933 zoledronic acid decreases expression ISO RGD:1319867 6480464 zoledronic acid results in decreased expression of EFNB2 mRNA CTD PMID:24714768